NOVAHISTINE DECON LIQ 5MG/5ML 5 MG / 5 ML
PHENYLEPHRINE HYDROCHLORIDE : 5 MG / 5 ML · DIN 01936670 · MERRELL PHARMS INC., DIVISION OF MERRELL DOW (CAN)
Health Canada status: CANCELLED POST MARKET
What is NOVAHISTINE DECON LIQ 5MG/5ML?
NOVAHISTINE DECON LIQ 5MG/5ML 5 MG / 5 ML contains PHENYLEPHRINE HYDROCHLORIDE : 5 MG / 5 ML. It is listed in the Health Canada Drug Product Database under DIN 01936670, held by MERRELL PHARMS INC., DIVISION OF MERRELL DOW (CAN), supplied as LIQUID for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 09-Sep-1996. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 01936670 |
|---|---|
| Brand name | NOVAHISTINE DECON LIQ 5MG/5ML |
| Generic / active ingredient | PHENYLEPHRINE HYDROCHLORIDE : 5 MG / 5 ML |
| Manufacturer | MERRELL PHARMS INC., DIVISION OF MERRELL DOW (CAN) |
| Strength | 5 MG / 5 ML |
| Dosage form | LIQUID |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | R01BA03 PHENYLEPHRINE |
| AHFS class | 12:12.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 09-Sep-1996 |
| Original market date | 1991-12-31 00:00:00 |
Is PHENYLEPHRINE in shortage in Canada?
A Canadian shortage report is on file for this molecule: Active — reported by OMEGA LABORATORIES LIMITED, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code R01BA03 PHENYLEPHRINE. 0 of 13 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| BENYLIN COLD STRIPS | 10 MG | STRIP | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | CANCELLED PRE MARKET | DIN 02262304 |
| BENYLIN D FOR INFANTS | 1.25 MG / 0.8 ML | SOLUTION | PFIZER CANADA INC., CONSUMER HEALTHCARE DIVISION | CANCELLED POST MARKET | DIN 02281341 |
| HELP I HAVE A STUFFY NOSE | 5 MG | TABLET | HELP REMEDIES INC | CANCELLED (UNRETURNED ANNUAL) | DIN 02374161 |
| HELP I HAVE THE SNIFFLES | 5 MG | TABLET | HELP REMEDIES INC | CANCELLED (UNRETURNED ANNUAL) | DIN 02376407 |
| LITTLE NOSES DECONGESTANT NOSE DROPS | 0.125 % | LIQUID | PRESTIGE BRANDS INC | CANCELLED POST MARKET | DIN 02270056 |
| NASAL DECONGESTANT | 10 MG | TABLET | JAMP PHARMA CORPORATION | APPROVED | DIN 02292548 |
| NOVAHISTINE DECONGESTANT - LIQ 5MG/5ML | 5 MG / 5 ML | LIQUID | HOECHST MARION ROUSSEL CANADA INC. | CANCELLED POST MARKET | DIN 02103001 |
| SINUS PE DECONGESTANT | 10 MG | TABLET | CELLCHEM PHARMACEUTICALS INC. | APPROVED | DIN 02322439 |
| SUDAFED PE EXTRA STRENGTH | 10 MG | TABLET | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | CANCELLED POST MARKET | DIN 02250217 |
| SUDAFED PE REGULAR STRENGTH | 5 MG | TABLET | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | CANCELLED PRE MARKET | DIN 02250209 |
Who else supplies PHENYLEPHRINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. PHENYLEPHRINE appears in 51 registered pack listings across 9 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.